ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least

August 18, 1978

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Talpin To Join NCI

June 27, 2003

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000